Key result
ApoA-I(Milano) was 2-fold more effective than apoA-I(Paris) in preventing lipoxygenase-mediated phospholipid oxidation, whereas wild-type apoA-I was poorly active.
Answers are grounded in this paper and cite their sources.
Apolipoprotein A-I(Milano) (apoA-I(Milano)) and apoA-I(Paris) are rare cysteine variants of apoA-I that produce a HDL deficiency in the absence of cardiovascular disease in humans. This paradox provides the basis for the hypothesis that the cysteine variants possess a beneficial activity not associated with wild-type apoA-I (apoA-I(WT)). In this study, a unique antioxidant activity of apoA-I(Milano) and apoA-I(Paris) is described. ApoA-I(Milano) was twice as effective as apoA-I(Paris) in preventing lipoxygenase-mediated oxidation of phospholipids, whereas apoA-I(WT) was poorly active. Antioxidant activity was observed using the monomeric form of the variants and was equally effective before and after initiation of oxidative events. ApoA-I(Milano) protected phospholipid from reactive oxygen species (ROS) generated via xanthine/xanthine oxidase (X/Xo) but failed to inhibit X/Xo-induced reduction of cytochrome c. These results indicate that apoA-I(Milano) was unable to directly quench ROS in the aqueous phase. There were no differences between lipid-free apoA-I(Milano,) apoA-I(Paris), and apoA-I(WT) in mediating the efflux of cholesterol from macrophages, indicating that the cysteine variants interacted normally with the ABCA1 efflux pathway. The results indicate that incorporation of a free thiol within an amphipathic alpha helix of apoA-I confers an antioxidant activity distinct from that of apoA-I(WT). These studies are the first to relate gain of function to rare cysteine mutations in the apoA-I primary sequence.
No takes yet. Share an insight, caveat, or question.
Bielicki et al. (2002) studied HDL deficiency / Cardiovascular disease. Apolipoprotein A-I(Milano) and Apolipoprotein A-I(Paris) vs. Wild-type apolipoprotein A-I (apoA-I(WT)) was evaluated on Prevention of lipoxygenase-mediated oxidation of phospholipids and reactive oxygen species (ROS)-mediated oxidation. ApoA-I(Milano) was 2-fold more effective than apoA-I(Paris) in preventing lipoxygenase-mediated phospholipid oxidation, whereas wild-type apoA-I was poorly active.
Synapse has enriched 10 related papers. Consider them for comparative context: